Join BJS Academy
BJS Academy>Randomized clinical ...>Effect of telmisarta...
Normal View Dyslexic View

Effect of telmisartan on walking performance in patients with lower extremity peripheral artery disease. The TELEX Randomized Clinical Trial.

24 November 2022
Randomized clinical trials Vascular
McDermott M, Bazzano L, Peterson CA, Sufit R, Ferrucci L, Domanchuk K et al.

JAMA 2022; 328: 1315-1325.

After six months, Telmisartan, an angiotensin receptor blocker, did not improve six-minute walking distance compared with placebo in this study that included 114 patients (P=0.08).

Comment: Still no good medicines for claudication.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct168
Randomized clinical trials
Randomized clinical trials
Vascular
Effect of telmisartan on walking performance in patients with lower extremity peripheral artery disease. The TELEX Randomized Clinical Trial.
McDermott M, Bazzano L, Peterson CA, Sufit R, Ferrucci L, Domanchuk K et al.
24112022
JAMA 2022; 328: 1315-1325.
After six months, Telmisartan, an angiotensin receptor blocker, did not improve six-minute walking distance compared with placebo in this study that included 114 patients (P=0.08).
Comment: Still no good medicines for claudication.
Published on: 24 November 2022
Article ID: rct168

Related articles

Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial.

Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS et al, on behalf of the Dutch Mesenteric Ischemia Study Group.

16 August 2024

Ten-year outcomes of a randomized clinical trial of endothermal ablation versus conventional surgery for great saphenous varicose veins

Mohamed AH, Howitt A, Rae S, Cai PL, Hitchman L, Wallace T et al.

18 September 2024

Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism. The Kids-DOTT randomized clinical trial.

Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA et al, for the Kids-DOTT Trial investigators and the ATLAS Group.
JAMA 2022; 327: 129-137.

1 February 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!